'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Gastritis to Gastrointestinal Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Gastritis to Gastrointestinal Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Gastritis Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Gastritis 30
Nov 03, 2016: RedHill Biopharma Provides Update on Ongoing Phase III and Phase II studies with BEKINDA and Expected Timing of Top-Line Results 30
Clinical Trial Profile Snapshots 31
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 109
List of Tables
Gastritis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Gastritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Gastritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Gastritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Gastritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Gastritis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Gastritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Gastritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Gastritis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14
Gastritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Gastritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Gastritis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17
Gastritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Gastritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Gastritis Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Gastritis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Gastritis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Gastritis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Gastritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Gastritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Gastritis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Gastritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Gastritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
List of Figures
Gastritis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Gastritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Gastritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Gastritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Gastritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Gastritis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Gastritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Gastritis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
Proportion of Gastritis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14
Gastritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Gastritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Gastritis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17
Gastritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Gastritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Gastritis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Gastritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Gastritis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Gastritis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Gastritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Gastritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Gastritis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Gastritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Gastritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 107